Deals & Capital MarketsJennifer Garner's Once Upon a Farm Pops 20% in NYSE Debut, Signals Consumer IPO Revival1h agoOFRMGIS+1 more
CorporateFactor Bioscience Takes Control of Tempest Therapeutics, Installs CEO Matt Angel After 74% Stock Collapse1h agoTPST
CorporatePyxis Oncology CEO Sullivan Steps Down After 88% Stock Plunge, Board Member Takes Reins1h agoPYXS